FDA prescription drug fees; booming ‘nonprofit’ hospitals; a primer on AI – Morning Medical Update
The top news stories in medicine today.
© Dz Lab - stock.adobe.com
Rules are in place for a reason, including the Prescription Drug User Fee Amendments of 2022, which pharmaceutical makers must follow when the U.S. Food and Drug Administration reviews new drugs. The rules also cost money -- $4.3 million to file for a drug using clinical data, starting Oct. 1. Here’s the official notice in the Federal Register and an analysis by Clinical Trials Arena.
Nonprofit hospitals in fact are diversified businesses that may still benefit from tax breaks and other financial advantages afforded to nonprofit organizations. They’re “operating surpluses” and investments may be eye-popping and another example of consolidation in health care. KFF has this perspective.
National health laws and regulations are important, but plenty of legislation and licensing that affect doctors happens at the state level. Meanwhile, artificial intelligence has boomed in health care and many analysts say that’s just getting started. Where do the two meet? The National Conference of State Legislatures this week updated “Artificial Intelligence & Health Care: A Primer,” with more.
